Toll-like receptor 4 signaling is required for induction of gluconeogenic gene expression by palmitate in human hepatic carcinoma cells

Journal of Nutritional Biochemistry

Volumn 24, Issue 8, 2013, Pages 1499-1507

  Mamedova, Laman K ^a   Yuan, Kai ^a   Laudick, Amber N ^a   Fleming, Sherry D ^a   Mashek, Douglas G ^b   Bradford, Barry J ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Diabetes; Gluconeogenesis; Palmitate; Saturated fatty acid; Toll like receptor 4

Indexed keywords

BOVINE SERUM ALBUMIN; CD36 ANTIGEN; CERAMIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOSE 6 PHOSPHATASE; GLUCOSE REGULATED PROTEIN 78; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PALMITIC ACID; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHORYL LIPID A; RESAZURIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GENE SILENCING; GLUCONEOGENESIS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LUCIFERASE ASSAY; MACROPHAGE; MURINAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REPORTER GENE; UPREGULATION;

DIABETES; GLUCONEOGENESIS; PALMITATE; SATURATED FATTY ACID; TOLL-LIKE RECEPTOR 4;

CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE-6-PHOSPHATASE; HEP G2 CELLS; HEPATOCYTES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID A; LIPOPOLYSACCHARIDES; LIVER NEOPLASMS; PALMITATES; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

BOVINAE;

EID: 84892433755     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.12.009     Document Type: Article

References (55)

1. Consoli A., Nurjhan N., Capani F., Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1989, 38:550-557.
2. Magnusson I., Rothman D.L., Katz L.D., Shulman R.G., Shulman G.I. Increased rate of gluconeogenesis in type II diabetes mellitus.A 13C nuclear magnetic resonance study. J Clin Invest 1992, 90:1323-1327.
3. Gastaldelli A., Baldi S., Pettiti M., Toschi E., Camastra S., Natali A., Ferrannini E., et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 2000, 49:1367-1373.
4. Brown M.S., Goldstein J.L. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 2008, 7:95-96.
5. Lam T.K.T., Van de Werve G., Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab 2003, 284:E281-E290.
6. Kehlenbrink S., Tonelli J., Koppaka S., Chandramouli V., Hawkins M., Kishore P. Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production. Am J Physiol Endocrinol Metab 2009, 297:E165-E173.
7. Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am 2008, 37:635-646.
8. Pankow J.S., Duncan B.B., Schmidt M.I., Ballantyne C.M., Couper D.J., Hoogeveen R.C., et al. Fasting plasma free fatty acids and risk of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care 2004, 27:77-82.
9. Wang L., Folsom A.R., Zheng Z.-J., Pankow J.S., Eckfeldt J.H. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2003, 78:91-98.
10. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4. J Biol Chem 2001, 276:16683-16689.
11. Wong S.W., Kwon M.-J., Choi A.M.K., Kim H.-P., Nakahira K., Hwang D.H. Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009, 284:27384-27392.
12. Radin M., Sinha S., Bhatt B., Dedousis N., O'Doherty R. Inhibition or deletion of the lipopolysaccharide receptor toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 2008, 51:336-346.
13. Galloway E., Shin T., Huber N., Eismann T., Kuboki S., Schuster R., et al. Activation of hepatocytes by extracellular heat shock protein 72. Am J Physiol Cell Physiol 2008, 295:C514-C520.
14. Li L., Chen L., Hu L., Liu Y., Sun H.-Y., Tang J., et al. Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology 2011, 54:1620-1630.
15. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
16. Tsukumo D.M.L., Carvalho-Filho M.A., Carvalheira J.B.C., Prada P.O., Hirabara S.M., Schenka A.A., et al. Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56:1986-1998.
17. Toshchakov V.Y., Fenton M.J., Vogel S.N. Cutting edge: differential inhibition of TLR signaling pathways by cell-permeable peptides representing BB loops of TLRs. J Immunol 2007, 178:2655-2660.
18. Fujita T., Nolan G.P., Liou H.-C., Scott M.L., Baltimore D. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev 1993, 7:1354-1363.
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
20. Sparkes B.L., Slone E.E., Roth M., Welti R., Fleming S.D. Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion. Biochim Biophys Acta 2010, 1801:517-525.
21. Mata-Haro V., Cekic C., Martin M., Chilton P.M., Casella C.R., Mitchell T.C. Thevaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 2007, 316:1628-1632.
22. Feldstein A.E., Werneburg N.W., Canbay A., Guicciardi M.E., Bronk S.F., Rydzewski R., et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004, 40:185-194.
23. Wei Y., Wang D., Topczewski F., Pagliassotti M.J. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 2006, 291:E275-E281.
24. Dobbins R.L., Szczepaniak L.S., Myhill J., Tamura Y., Uchino H., Giacca A., et al. The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes 2002, 51:1825-1833.
25. Boden G., Chen X., Capulong E., Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 2001, 50:810-816.
26. Collins Q.F., Xiong Y., Lupo E.G., Liu H.-Y., Cao W. p38 mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes. J Biol Chem 2006, 281:24336-24344.
27. Gao D., Nong S., Huang X., Lu Y., Zhao H., Lin Y., et al. The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem 2010, 285:29965-29973.
28. Massillon D., Barzilai N., Hawkins M., Prus-Wertheimer D., Rossetti L. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes 1997, 46:153-157.
29. Xu C., Chakravarty K., Kong X., Tuy T.T., Arinze I.J., Bone F., et al. Several transcription factors are recruited to the glucose-6-phosphatase gene promoter in response to palmitate in rat hepatocytes and H4IIE cells. J Nutr 2007, 137:554-559.
30. Wan X.D., Yang W.B., Xia Y.Z., Wang J.F., Lu T., Wang X.M. Disruption of glucose homeostasis and induction of insulin resistance by elevated free fatty acids in human L02 hepatocytes. J Endocrinol Invest 2009, 32:454-459.
31. Baldeweg S.E., Golay A., Natali A., Balkau B., Del Prato S., Coppack S.W. Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. Eur J Clin Invest 2000, 30:45-52.
32. Jump D.B., Botolin D., Wang Y., Xu J., Christian B., Demeure O. Fatty acid regulation ofhepatic gene transcription. J Nutr 2005, 135:2503-2506.
33. Nakamura S., Takamura T., Matsuzawa-Nagata N., Takayama H., Misu H., Noda H., et al. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem 2009, 284:14809-14818.
34. Holland W.L., Bikman B.T., Wang L.-P., Yuguang G., Sargent K.M., Bulchand S., et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 2011, 121:1858-1870.
35. Bikman B.T., Summers S.A. Ceramides as modulators of cellularand whole-body metabolism. J Clin Invest 2011, 121:4222-4230.
36. Summers S.A., Garza L.A., Zhou H., Birnbaum M.J. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 1998, 18:5457-5464.
37. Holland W.L., Brozinick J.T., Wang L.P., Hawkins E.D., Sargent K.M., Liu Y., et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007, 5:167-179.
38. Smith B.K., Jain S.S., Rimbaud S., Dam A., Quadrilatero J., Ventura-Clapier R., et al. FAT/CD36 is located on the outer mitochondrial membrane, upstream of long-chain acyl-CoA synthetase, and regulates palmitate oxidation. Biochem J 2011, 437:125-134.
39. Lee J.Y., Ye J., Gao Z., Youn H.S., Lee W.H., Zhao L., et al. Reciprocal modulation of toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 2003, 278:37041-37051.
40. Lee J.Y., Zhao L., Hwang D.H. Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids. Nutr Rev 2010, 68:38-61.
41. Simons K., Toomre D. Lipid rafts and membrane dynamics. Nat Rev Mol Cell Biol 2000, 1:31-39.
42. Ferré P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004, 53:S43-S50.
43. Zhang L.L., Gao C.Y., Fang C.Q., Wang Y.J., Gao D., Yao G.E., et al. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Cardiovasc Res 2011, 92:484-493.
44. Martin M., Michalek S.M., Katz J. Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect Immun 2003, 71:2498-2507.
45. Núñez Miguel R., Wong J., Westoll J.F., Brooks H.J., O'Neill L.A., Gay N.J., et al. A dimer of the toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signaling adaptor proteins. PLoS One 2007, 2:e788.
46. Cekic C., Casella C.R., Eaves C.A., Matsuzawa A., Ichijo H., Mitchell T.C. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A. J Biol Chem 2009, 284:31982-31991.
47. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2011, 413:131-138.
48. Senn J.J. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J Biol Chem 2006, 281:26865-26875.
49. Cao W., Collins Q.F., Becker T.C., Robidoux J., Lupo E.G., Xiong Y., et al. p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis. J Biol Chem 2005, 280:42731-42737.
50. Nakatani Y., Kaneto H., Kawamori D., Hatazaki M., Miyatsuka T., Matsuoka T.A., et al. Modulation of the JNK pathway in liver affects insulin resistance status. J Biol Chem 2004, 279:45803-45809.
51. Danno H., Ishii K.A., Nakagawa Y., Mikami M., Yamamoto T., Yabe S., et al. The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARα. Biochem Biophys Res Commun 2010, 391:1222-1227.
52. Lee M.W., Chanda D., Yang J., Oh H., Kim S., Yoon Y.S., et al. Regulation of hepatic gluconeogenesis by an ER bound transcription factor. CREBH. Cell Metab 2010, 11:331-339.
53. Zhang K., Shen X., Wu J., Sakaki K., Saunders T., Rutkowski D.T., et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 2006, 124:587-599.
54. Gentile C.L., Wang D., Pfaffenbach K.T. Fatty acids regulate CREBh via transcriptional mechanisms that are dependent on proteasome activity and insulin. Mol Cell Biochem 2010, 344:99-107.
55. Zhou H., Zhang Y., Fu Y., Chan L., Lee A.S. Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78). J Biol Chem 2011, 286:25687-25696.